検索
Eikon Therapeutics Ord Shs
EIKNウォッチリストに追加
12.540USD
+0.290+2.37%
終値 07/02, 13:00（ET）15分遅れの株価
663.20M時価総額
損失額直近12ヶ月PER
詳細情報 Eikon Therapeutics Ord Shs 企業名
Eikon Therapeutics Ord Shsの企業情報
企業コードEIKN
会社名Eikon Therapeutics Inc
上場日Feb 05, 2026
最高経営責任者「CEO」Perlmutter (Roger M)
従業員数384
証券種類Ordinary Share
決算期末Feb 05
本社所在地230 Harriet Tubman Way
都市MILLBRAE
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94030
電話番号13026587581
ウェブサイトhttps://eikontx.com/
企業コードEIKN
上場日Feb 05, 2026
最高経営責任者「CEO」Perlmutter (Roger M)
Eikon Therapeutics Ord Shsの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Benjamin Thorner
Mr. Benjamin Thorner
Chief Business Officer, General Counsel
Chief Business Officer, General Counsel
--
--
Dr. Leon Chen, Ph.D.
Dr. Leon Chen, Ph.D.
Director
Director
--
--
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
よくある質問
Eikon Therapeutics Ord Shsの上位5名の株主は誰ですか？
Eikon Therapeutics Ord Shsの上位5名の株主は以下のとおりです。Dr. Roger M. Perlmutter, M.D., Ph.D.